SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-132306
Filing Date
2020-12-04
Accepted
2020-12-04 12:30:16
Documents
19
Period of Report
2020-12-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2037645d1_8k.htm   iXBRL 8-K 27453
2 EXHIBIT 99.1 tm2037645d1_ex99-1.htm EX-99.1 43228
6 GRAPHIC tm2037645d1_ex99-1img001.jpg GRAPHIC 7521
7 GRAPHIC tm2037645d1_ex99-1img002.jpg GRAPHIC 17091
8 GRAPHIC tm2037645d1_ex99-1img003.jpg GRAPHIC 21400
9 GRAPHIC tm2037645d1_ex99-1img004.jpg GRAPHIC 17078
10 GRAPHIC tm2037645d1_ex99-1img005.jpg GRAPHIC 23372
11 GRAPHIC tm2037645d1_ex99-1img006.jpg GRAPHIC 44893
  Complete submission text file 0001104659-20-132306.txt   437365

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyne-20201204.xsd EX-101.SCH 3183
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyne-20201204_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyne-20201204_pre.xml EX-101.PRE 22708
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2037645d1_8k_htm.xml XML 3730
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37526 | Film No.: 201369330
SIC: 2834 Pharmaceutical Preparations